Reference Title EndPoint Method
Reference Title EndPoint Method
DPF-0006DPF, cytokine release ( PMA stimulation)*** (must be login)*** (must be login)
DPF-0016DPF, estrogen metabolism & aromatase activity (basal)*** (must be login)*** (must be login)
DPF-0024DPF, GAG synthesis (basal)*** (must be login)*** (must be login)
DPF-0023DPF, PGD2 release ( IL-1 alpha stimulation)*** (must be login)*** (must be login)
DPF-0008DPF, PGE2 release ( IL-1 alpha stimulation)*** (must be login)*** (must be login)
DPF-0007DPF, PGE2 release (PMA stimulation)*** (must be login)*** (must be login)
DPF-0021DPF, PGF2 release (basal)*** (must be login)*** (must be login)
DPF-0002DPF, proliferation (basal)ProliferationBrdU incorporation / Photometry
DPF-0020DPF, proliferation (hydrocortisone stimulation)*** (must be login)*** (must be login)
DPF-0025DPF, sulfated GAG synthesis (basal)*** (must be login)*** (must be login)
DPF-0001DPF, testosterone metabolism & 5- alpha reductase activity (basal)5- alpha reductase activity[14C]-testosterone incorporation
DPF-0015DPF, VEGF release (basal)*** (must be login)*** (must be login)
DRG-0001DRG network (basal)beta-III tubulin labelingImmunofluorescence
DRG-0002DRG network (cisplatin-intoxicated)beta-III tubulin labelingImmunofluorescence
EPI&DE-0001Epidermis/Dermis, keratinocyte migration (basal)*** (must be login)*** (must be login)